FL
UTHR icon

Fort LP’s United Therapeutics UTHR Stock Holding History

Fort LP’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-948
Closed -$214K – 150
2023
Q3 		$214K Sell
948
-139
-13% -$32K 0.59% 114
2023
Q2 		$240K Buy
1,087
+10
+0.9% +$2.21K 0.63% 102
2023
Q1 		$241K Sell
1,077
-67
-6% -$16.5K 0.62% 110
2022
Q4 		$318K Buy
1,144
+50
+5% +$12.6K 0.48% 119
2022
Q3 		$229K Sell
1,094
-430
-28% -$96.1K 0.29% 186
2022
Q2 		$359K Sell
1,524
-938
-38% -$191K 0.24% 186
2022
Q1 		$442K Sell
2,462
-1,903
-44% -$363K 0.17% 219
2021
Q4 		$943K Sell
4,365
-3,209
-42% -$630K 0.31% 164
2021
Q3 		$1.4M Sell
7,574
-2,735
-27% -$539K 0.47% 100
2021
Q2 		$1.85M Sell
10,309
-2,080
-17% -$396K 0.53% 41
2021
Q1 		$2.07M Buy
12,389
+1,342
+12% +$224K 0.58% 14
2020
Q4 		$1.68M Buy
11,047
+5,395
+95% +$708K 0.5% 79
2020
Q3 		$571K Buy
+5,652
New +$620K 0.24% 183
2020
Q1 		– Sell
-217
Closed -$19K – 458
2019
Q4 		$19K Hold
217
– – ﹤0.01% 439
2019
Q3 		$17K Sell
217
-1,305
-86% -$105K ﹤0.01% 408
2019
Q2 		$119K Buy
1,522
+1,312
+625% +$123K 0.02% 331
2019
Q1 		$25K Buy
+210
New +$24.5K 0.01% 401
2017
Q3 		– Sell
-2,014
Closed -$261K – 49
2017
Q2 		$261K Buy
2,014
+99
+5% +$12.3K 0.07% 48
2017
Q1 		$259K Sell
1,915
-3,321
-63% -$503K 0.07% 50
2016
Q4 		$751K Sell
5,236
-16,861
-76% -$2.15M 0.21% 48
2016
Q3 		$2.61M Buy
22,097
+4,579
+26% +$550K 0.9% 31
2016
Q2 		$1.86M Buy
17,518
+1,155
+7% +$129K 0.76% 31
2016
Q1 		$1.82M Buy
16,363
+2,920
+22% +$369K 0.77% 30
2015
Q4 		$2.1M Buy
+13,443
New +$1.96M 1% 30

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fort LP's UTHR Position: Q4 2023 in Review

Fort LP sold out of United Therapeutics (UTHR) in Q4 2023, closing a stake of 948 shares — an estimated $214K sold.

Fort LP first reported a position in UTHR in Q4 2015 and held it in 24 quarters. The position peaked at $2.61M in Q3 2016. 535 funds tracked by Wall St. Rank hold UTHR as of Q4 2023.

  • Fort LP reported no remaining United Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Fort LP sold 948 United Therapeutics shares in Q4 2023, an estimated $214K.
  • Fort LP first reported a position in United Therapeutics in Q4 2015 and held it in 24 quarters.
  • Fort LP's United Therapeutics position peaked at $2.61M in Q3 2016.
  • 535 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2023.

Based on Fort LP's 13F filing for Q4 2023, filed 14 Feb 2024.